Childhood ocular myasthenia gravis. 2003

Jong-Hyun Kim, and Jeong-Min Hwang, and Yong Seung Hwang, and Ki Joong Kim, and Jonghee Chae
Department of Ophthalmology, Seoul National University College of Medicine, Seoul, South Korea.

OBJECTIVE To investigate the clinical manifestations and ocular findings in children with ocular myasthenia gravis (MG) that rarely have been reported in the literature. METHODS Retrospective, noncomparative case series. METHODS Twenty-four consecutive patients less than 15 years of age with ocular MG treated between June 1988 and July 2001. METHODS The medical records of 6 boys and 18 girls with ocular MG were reviewed retrospectively. METHODS Alternate prism cover and uncover test, examination of ductions and versions, and visual acuity. RESULTS Mean age at onset was 38 months. Ptosis was found in 23 patients (96%), strabismus in 21 patients (88%), and amblyopia in 5 patients (21%). Exotropia combined with vertical heterotropia was the most frequent type of strabismus. Ductions were limited in 17 patients (71%), among whom supraduction or infraduction limitations were most frequently observed. Contrary to previous reports, medial rectus underaction was less common than lateral rectus underaction. Manifestations of strabismus and limitation of duction were variable and changed frequently during the follow-up period. The combined use of prednisone and pyridostigmine was found to be the predominant form of maintenance therapy, and ptosis was more responsive to drug therapy than limited ocular motility. CONCLUSIONS Children with ocular MG were found to have a high incidence of ptosis (96%) and exotropia and vertical hyperdeviation. Limitation on adduction was less common than that on abduction. First reported incidence of amblyopia (21%) and a relative nonresponsiveness of the limitation of eye movement to treatment were also noted.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008297 Male Males
D009157 Myasthenia Gravis A disorder of neuromuscular transmission characterized by fatigable weakness of cranial and skeletal muscles with elevated titers of ACETYLCHOLINE RECEPTORS or muscle-specific receptor tyrosine kinase (MuSK) autoantibodies. Clinical manifestations may include ocular muscle weakness (fluctuating, asymmetric, external ophthalmoplegia; diplopia; ptosis; and weakness of eye closure) and extraocular fatigable weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles (ocular myasthenia). THYMOMA is commonly associated with this condition. Anti-MuSK Myasthenia Gravis,MuSK MG,MuSK Myasthenia Gravis,Muscle-Specific Receptor Tyrosine Kinase Myasthenia Gravis,Muscle-Specific Tyrosine Kinase Antibody Positive Myasthenia Gravis,Myasthenia Gravis, Generalized,Myasthenia Gravis, Ocular,Anti MuSK Myasthenia Gravis,Generalized Myasthenia Gravis,Muscle Specific Receptor Tyrosine Kinase Myasthenia Gravis,Muscle Specific Tyrosine Kinase Antibody Positive Myasthenia Gravis,Myasthenia Gravis, Anti-MuSK,Myasthenia Gravis, MuSK,Ocular Myasthenia Gravis
D011241 Prednisone A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver. Dehydrocortisone,delta-Cortisone,Apo-Prednisone,Cortan,Cortancyl,Cutason,Dacortin,Decortin,Decortisyl,Deltasone,Encorton,Encortone,Enkortolon,Kortancyl,Liquid Pred,Meticorten,Orasone,Panafcort,Panasol,Predni Tablinen,Prednidib,Predniment,Prednison Acsis,Prednison Galen,Prednison Hexal,Pronisone,Rectodelt,Sone,Sterapred,Ultracorten,Winpred,Acsis, Prednison
D011729 Pyridostigmine Bromide A cholinesterase inhibitor with a slightly longer duration of action than NEOSTIGMINE. It is used in the treatment of myasthenia gravis and to reverse the actions of muscle relaxants. Mestinon,Pyridostigmine,Bromide, Pyridostigmine
D001763 Blepharoptosis Drooping of the upper lid due to deficient development or paralysis of the levator palpebrae muscle. Ptosis, Eyelid,Blepharoptoses,Eyelid Ptoses,Eyelid Ptosis,Ptoses, Eyelid
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003941 Diagnostic Techniques, Ophthalmological Methods and procedures for the diagnosis of diseases of the eye or of vision disorders. Diagnostic Technic, Ophthalmological,Diagnostic Technics, Ophthalmologic,Diagnostic Technics, Ophthalmological,Diagnostic Technique, Ophthalmological,Diagnostic Techniques, Ophthalmologic,Ophthalmological Diagnostic Technic,Ophthalmological Diagnostic Technics,Ophthalmological Diagnostic Technique,Ophthalmological Diagnostic Techniques,Technic, Ophthalmological Diagnostic,Technics, Ophthalmological Diagnostic,Technique, Ophthalmological Diagnostic,Techniques, Ophthalmological Diagnostic,Diagnostic Technic, Ophthalmologic,Diagnostic Technique, Ophthalmologic,Ophthalmologic Diagnostic Technic,Ophthalmologic Diagnostic Technics,Ophthalmologic Diagnostic Technique,Ophthalmologic Diagnostic Techniques,Technic, Ophthalmologic Diagnostic,Technics, Ophthalmologic Diagnostic,Technique, Ophthalmologic Diagnostic,Techniques, Ophthalmologic Diagnostic
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug

Related Publications

Jong-Hyun Kim, and Jeong-Min Hwang, and Yong Seung Hwang, and Ki Joong Kim, and Jonghee Chae
January 2007, International ophthalmology clinics,
Jong-Hyun Kim, and Jeong-Min Hwang, and Yong Seung Hwang, and Ki Joong Kim, and Jonghee Chae
November 2012, Current opinion in ophthalmology,
Jong-Hyun Kim, and Jeong-Min Hwang, and Yong Seung Hwang, and Ki Joong Kim, and Jonghee Chae
May 2013, Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft,
Jong-Hyun Kim, and Jeong-Min Hwang, and Yong Seung Hwang, and Ki Joong Kim, and Jonghee Chae
September 2004, Ophthalmology clinics of North America,
Jong-Hyun Kim, and Jeong-Min Hwang, and Yong Seung Hwang, and Ki Joong Kim, and Jonghee Chae
January 2005, Current treatment options in neurology,
Jong-Hyun Kim, and Jeong-Min Hwang, and Yong Seung Hwang, and Ki Joong Kim, and Jonghee Chae
September 1993, Journal of the National Medical Association,
Jong-Hyun Kim, and Jeong-Min Hwang, and Yong Seung Hwang, and Ki Joong Kim, and Jonghee Chae
January 2023, Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova,
Jong-Hyun Kim, and Jeong-Min Hwang, and Yong Seung Hwang, and Ki Joong Kim, and Jonghee Chae
March 1997, Archives of neurology,
Jong-Hyun Kim, and Jeong-Min Hwang, and Yong Seung Hwang, and Ki Joong Kim, and Jonghee Chae
July 2001, Current treatment options in neurology,
Jong-Hyun Kim, and Jeong-Min Hwang, and Yong Seung Hwang, and Ki Joong Kim, and Jonghee Chae
January 1977, Journal of pediatric ophthalmology,
Copied contents to your clipboard!